Bergen, Norway 5 Januar 2023 2022 was a very good year for Lifecare as a company and we welcome 2023 expecting continued significant progress in our mission to make life easier for patients with diabetes. Throughout 2022 Lifecare disclosed several milestone events, read more in letter from Lifecare's CEO published today: https://lifecare.no/news/happy-new-year/ This is Lifecare: Lifecare is aBergen -based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers.Lifecare AS is listed on Euronext Growth (LIFE). Further informationJoacim Holter , CEO,Lifecare AS , joacim.holter@lifecare.no, +47 40 05 90 40This stock exchange announcement was published byJoacim Holter , CEO atLifecare AS , on5.1.23 at14:00 CET .
Click here for more information
© Oslo Bors ASA, source